Phreesia (NYSE:PHR) General Counsel Allison Hoffman Sells 6,176 Shares of Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison Hoffman sold 6,176 shares of the stock in a transaction that occurred on Monday, April 20th. The stock was sold at an average price of $9.06, for a total value of $55,954.56. Following the sale, the general counsel directly owned 157,309 shares of the company’s stock, valued at $1,425,219.54. The trade was a 3.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Phreesia Stock Down 1.1%

Phreesia stock opened at $9.33 on Wednesday. The company has a current ratio of 1.53, a quick ratio of 1.53 and a debt-to-equity ratio of 0.41. The stock has a 50 day moving average of $10.82 and a two-hundred day moving average of $16.01. The stock has a market capitalization of $566.59 million, a price-to-earnings ratio of 310.83 and a beta of 0.86. Phreesia, Inc. has a twelve month low of $7.77 and a twelve month high of $32.76.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Monday, March 30th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.05). The business had revenue of $127.07 million during the quarter, compared to analyst estimates of $126.75 million. Phreesia had a net margin of 0.48% and a return on equity of 3.23%. The firm’s quarterly revenue was up 15.9% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.11) earnings per share. As a group, research analysts expect that Phreesia, Inc. will post 0.36 earnings per share for the current year.

Hedge Funds Weigh In On Phreesia

Several hedge funds have recently bought and sold shares of the company. OP Asset Management Ltd purchased a new position in Phreesia in the 1st quarter valued at approximately $6,487,000. SG Americas Securities LLC increased its stake in Phreesia by 544.3% in the 1st quarter. SG Americas Securities LLC now owns 457,925 shares of the company’s stock valued at $3,837,000 after purchasing an additional 386,848 shares in the last quarter. Diversified Trust Co increased its stake in Phreesia by 5.8% in the 1st quarter. Diversified Trust Co now owns 54,418 shares of the company’s stock valued at $456,000 after purchasing an additional 2,996 shares in the last quarter. Hsbc Holdings PLC increased its stake in Phreesia by 96.2% in the 4th quarter. Hsbc Holdings PLC now owns 46,558 shares of the company’s stock valued at $786,000 after purchasing an additional 22,829 shares in the last quarter. Finally, Rockefeller Capital Management L.P. increased its stake in Phreesia by 354.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock valued at $47,000 after purchasing an additional 2,149 shares in the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have recently commented on PHR. Wells Fargo & Company reduced their price target on Phreesia from $30.00 to $25.00 and set an “overweight” rating for the company in a report on Thursday, March 26th. Stephens reduced their price target on Phreesia from $32.00 to $20.00 and set an “overweight” rating for the company in a report on Tuesday, March 31st. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $16.00 price target (down from $24.00) on shares of Phreesia in a report on Tuesday, March 31st. Needham & Company LLC reduced their price target on Phreesia from $35.00 to $14.00 and set a “buy” rating for the company in a report on Tuesday, March 31st. Finally, Robert W. Baird reissued a “neutral” rating and issued a $10.00 price target (down from $25.00) on shares of Phreesia in a report on Tuesday, March 31st. Twelve equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $20.82.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.